Label: BIO DNA SERUM- glycerin liquid

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 7, 2017

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Glycerin

  • INACTIVE INGREDIENT

    Niacinamide, Adenosine, DNA, All 6 Jewels, etc.

  • PURPOSE

    Multi-Function - Wrinkle, Brightening, Moisturizing

  • KEEP OUT OF REACH OF CHILDREN

    keep out or reach of the children

  • INDICATIONS & USAGE

    Take appropriate amount and evenly apply it to the skin

  • WARNINGS

    If you experience following symptoms after using the cosmetics, you should immediately stop using the cosmetics. If you continue to use them, the symptoms may worsen. Consult with your dermatologist.
    A) When you experience red spots, swelling, itchiness and irritation while applying the product.
    B) When the applied area experience symptoms while it is exposed to direct sunlight
    2. Do not use the cosmetics on the areas where you have wounds, eczema or dermatitis
    3. Precautions when storing and using the product
    A) Keep the lid closed after using the product
    B) Store it out of reach of children
    C) Do not store it in places with high or low temperature or where it is exposed to the sunlight directly.

  • DOSAGE & ADMINISTRATION

    for external use only


  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    BIO DNA SERUM 
    glycerin liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70514-0006
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN10.82 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    NIACINAMIDE (UNII: 25X51I8RD4)  
    ADENOSINE (UNII: K72T3FS567)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70514-0006-140 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product11/29/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart34711/29/2017
    Labeler - Karatica Co., Ltd (689605545)
    Registrant - Karatica Co., Ltd (689605545)
    Establishment
    NameAddressID/FEIBusiness Operations
    Karatica Co., Ltd689605545manufacture(70514-0006)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!